The Latest Breaking News from Cigna

Cigna Group has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Asian shares are trading mostly lower, despite a rally on Wall Street in stocks seen as benefiting the most from Donald Trump’s reelection as president

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….

Cigna Group is set to announce its fiscal third-quarter earnings next week, and analysts anticipate a modest single-digit profit increase.

The Dow Jones fell on the stock market today. Walt Disney announced details on replacing CEO Bob Iger. Nvidia hit a record as Boeing jumped.

Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled.

The Cigna Group has outperformed the Nasdaq Composite over the past year and analysts remain bullish about the stock’s prospects.

Cigna Group has underperformed the broader market over the past year, but Wall Street analysts are optimistic about the stock’s prospects.

September Nasdaq 100 E-Mini futures (NQU24) are up +0.36% this morning as strong quarterly results from Meta Platforms and dovish comments from Federal Reserve Chair Jerome Powell boosted sentiment, while investors awaited a new round of U.S. economic data and earnings reports.

Here’s a dividend-paying gem trading at an attractive valuation, which investors can consider this July while it's still a bargain.

Cigna Group is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit increase.